Supplemental Table S12:

In silico variant effect predictions for selected variants seen in All of Us, accessed through dbNSFP (last updated March 13, 2024). Scores interpreted according to ClinGen recommendations for PP3/BP4 criteria (PMID 36413997). ENST00000393562 was used for all tools for which it was available (BayesDel, CADD, GERP++, PrimateAI, REVEL, MPC, PolyPhen-2 HumVar), and ENST00000393564 was used for the remaining tools (SIFT, FATHMM, VEST4). Scores from FATHMM and CADD were not included in final analysis because they predicted all tested variants to be pathogenic and benign, respectively. If other tools predicted conflicting evidence for benignity or pathogenicity, consensus was taken when more than ⅔ agreed and no more than one tool dissented, and the consensus was used at supporting level of evidence. If multiple tools provided non-conflicting evidence, the lowest level of support was conservatively used.

Provided as file attachment “Supplemental_Table_S12.xlsx”.